These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 35959876)

  • 21. Comparison of Human Hematopoietic Reconstitution in Different Strains of Immunodeficient Mice.
    Beyer AI; Muench MO
    Stem Cells Dev; 2017 Jan; 26(2):102-112. PubMed ID: 27758159
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An Oncolytic Virus Expressing IL15/IL15Rα Combined with Off-the-Shelf EGFR-CAR NK Cells Targets Glioblastoma.
    Ma R; Lu T; Li Z; Teng KY; Mansour AG; Yu M; Tian L; Xu B; Ma S; Zhang J; Barr T; Peng Y; Caligiuri MA; Yu J
    Cancer Res; 2021 Jul; 81(13):3635-3648. PubMed ID: 34006525
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Promising preclinical platform for evaluation of immuno-oncology drugs using Hu-PBL-NSG lung cancer models.
    Pyo KH; Kim JH; Lee JM; Kim SE; Cho JS; Lim SM; Cho BC
    Lung Cancer; 2019 Jan; 127():112-121. PubMed ID: 30642538
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulation of human cell engraftment and development of EBV-related lymphoproliferative disorders in Hu-PBL-scid mice.
    Wagar EJ; Cromwell MA; Shultz LD; Woda BA; Sullivan JL; Hesselton RM; Greiner DL
    J Immunol; 2000 Jul; 165(1):518-27. PubMed ID: 10861091
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Generation of functional human T-cell subsets with HLA-restricted immune responses in HLA class I expressing NOD/SCID/IL2r gamma(null) humanized mice.
    Shultz LD; Saito Y; Najima Y; Tanaka S; Ochi T; Tomizawa M; Doi T; Sone A; Suzuki N; Fujiwara H; Yasukawa M; Ishikawa F
    Proc Natl Acad Sci U S A; 2010 Jul; 107(29):13022-7. PubMed ID: 20615947
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NOD-scidIl2rg (tm1Wjl) and NOD-Rag1 (null) Il2rg (tm1Wjl) : a model for stromal cell-tumor cell interaction for human colon cancer.
    Maykel J; Liu JH; Li H; Shultz LD; Greiner DL; Houghton J
    Dig Dis Sci; 2014 Jun; 59(6):1169-79. PubMed ID: 24798995
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Natural killer cells generated from cord blood hematopoietic progenitor cells efficiently target bone marrow-residing human leukemia cells in NOD/SCID/IL2Rg(null) mice.
    Cany J; van der Waart AB; Tordoir M; Franssen GM; Hangalapura BN; de Vries J; Boerman O; Schaap N; van der Voort R; Spanholtz J; Dolstra H
    PLoS One; 2013; 8(6):e64384. PubMed ID: 23755121
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sarcoma IL-12 overexpression facilitates NK cell immunomodulation.
    Rademacher MJ; Cruz A; Faber M; Oldham RAA; Wang D; Medin JA; Schloemer NJ
    Sci Rep; 2021 Apr; 11(1):8321. PubMed ID: 33859303
    [TBL] [Abstract][Full Text] [Related]  

  • 29. NOD/scid IL-2Rg(null) mice: a preclinical model system to evaluate human dendritic cell-based vaccine strategies in vivo.
    Spranger S; Frankenberger B; Schendel DJ
    J Transl Med; 2012 Feb; 10():30. PubMed ID: 22364226
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CD8-positive lymphocytes in graft-versus-host disease of humanized NOD.Cg-Prkdc(scid)Il2rg(tm1Wjl)/SzJ mice.
    Laing ST; Griffey SM; Moreno ME; Stoddart CA
    J Comp Pathol; 2015; 152(2-3):238-42. PubMed ID: 25670669
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differences in Tumor Growth and Differentiation in NSG and Humanized-BLT Mice; Analysis of Human vs. Humanized-BLT-Derived NK Expansion and Functions.
    Kaur K; Jewett A
    Cancers (Basel); 2022 Dec; 15(1):. PubMed ID: 36612108
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-tumor effects of anti-PD-1 antibody, pembrolizumab, in humanized NSG PDX mice xenografted with dedifferentiated liposarcoma.
    Choi B; Lee JS; Kim SJ; Hong D; Park JB; Lee KY
    Cancer Lett; 2020 May; 478():56-69. PubMed ID: 32145342
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NOD/SCID/gamma(c)(null) mouse: an excellent recipient mouse model for engraftment of human cells.
    Ito M; Hiramatsu H; Kobayashi K; Suzue K; Kawahata M; Hioki K; Ueyama Y; Koyanagi Y; Sugamura K; Tsuji K; Heike T; Nakahata T
    Blood; 2002 Nov; 100(9):3175-82. PubMed ID: 12384415
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of human CD4+FoxP3+ regulatory T cells in human stem cell factor-, granulocyte-macrophage colony-stimulating factor-, and interleukin-3-expressing NOD-SCID IL2Rγ(null) humanized mice.
    Billerbeck E; Barry WT; Mu K; Dorner M; Rice CM; Ploss A
    Blood; 2011 Mar; 117(11):3076-86. PubMed ID: 21252091
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interleukin-15 plays an essential role in the pathogenesis of autoimmune diabetes in the NOD mouse.
    Bobbala D; Chen XL; Leblanc C; Mayhue M; Stankova J; Tanaka T; Chen YG; Ilangumaran S; Ramanathan S
    Diabetologia; 2012 Nov; 55(11):3010-20. PubMed ID: 22890824
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Autonomous growth and increased cytotoxicity of natural killer cells expressing membrane-bound interleukin-15.
    Imamura M; Shook D; Kamiya T; Shimasaki N; Chai SM; Coustan-Smith E; Imai C; Campana D
    Blood; 2014 Aug; 124(7):1081-8. PubMed ID: 25006133
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Natural killer cell depletion by anti-asialo GM1 antiserum treatment enhances human hematopoietic stem cell engraftment in NOD/Shi-scid mice.
    Yoshino H; Ueda T; Kawahata M; Kobayashi K; Ebihara Y; Manabe A; Tanaka R; Ito M; Asano S; Nakahata T; Tsuji K
    Bone Marrow Transplant; 2000 Dec; 26(11):1211-6. PubMed ID: 11149733
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of mature and functional human myeloid subsets in hematopoietic stem cell-engrafted NOD/SCID/IL2rγKO mice.
    Tanaka S; Saito Y; Kunisawa J; Kurashima Y; Wake T; Suzuki N; Shultz LD; Kiyono H; Ishikawa F
    J Immunol; 2012 Jun; 188(12):6145-55. PubMed ID: 22611244
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MHC class I and II-deficient humanized mice are suitable tools to test the long-term antitumor efficacy of immune checkpoint inhibitors and T-cell engagers.
    Eguren-Santamaria I; Fernández de Piérola E; Camps G; Martín-Muñoz P; Campos M; Cuculescu D; Aguilera-Buenosvinos I; Rodríguez López I; Salido-Vallejo R; Alexandru R; De Andrea CE; Álvarez-Gigli L; Berraondo P; Melero I; Sanmamed MF
    J Immunother Cancer; 2024 Sep; 12(9):. PubMed ID: 39244214
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improved B cell development in humanized NOD
    Jangalwe S; Shultz LD; Mathew A; Brehm MA
    Immun Inflamm Dis; 2016 Dec; 4(4):427-440. PubMed ID: 27980777
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.